Showing results (411-420 of 491) with videos related to

Sort By:
Pageof 50
Leukemia & Lymphoma|February 10, 2022
Impact of omitting post-transplant minidose-methotrexate doses in allogeneic hematopoietic cell transplantationAndrew Lin, Samantha Brown, Molly Maloy, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2019
Immune Cytopenias after Ex Vivo CD34+-Selected Allogeneic Hematopoietic Cell TransplantationMichael Scordo, Meier Hsu, Ann A Jakubowski, et al.
Bone Marrow Transplantation|January 27, 2015
Comparison of outcomes at two institutions of patients with ALL receiving ex vivo T-cell-depleted or unmodified allograftsG S Hobbs, A Hamdi, P D Hilden, et al.
Critical Care Medicine|July 9, 2004
Evaluation of protein C and other biomarkers as predictors of mortality in a rat cecal ligation and puncture model of sepsisJosef G Heuer, Ganesh R Sharma, Bruce Gerlitz, et al.
Bone Marrow Transplantation|July 10, 2007
Long-term follow-up of patients treated with daclizumab for steroid-refractory acute graft-vs-host diseaseM-A Perales, N Ishill, W A Lomazow, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 29, 2018
Early Fluid Overload Is Associated with an Increased Risk of Nonrelapse Mortality after Ex Vivo CD34-Selected Allogeneic Hematopoietic Cell TransplantationCarlos Rondon-Clavo, Michael Scordo, Patrick Hilden, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 8, 2013
Ex vivo T cell-depleted versus unmodified allografts in patients with acute myeloid leukemia in first complete remissionUlas D Bayraktar, Marcos de Lima, Rima M Saliba, et al.
Leukemia & Lymphoma|December 6, 2011
Long-term survival in patients with peripheral T-cell non-Hodgkin lymphomas after allogeneic hematopoietic stem cell transplantJenna D Goldberg, Joanne F Chou, Steven Horwitz, et al.
Pageof 50